The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia
| Image |  |
|---|---|
| Description | scientific article published on 27 August 2020 |
| Author/s |
author: Prashant Sharma Shano Naseem Sreejesh Sreedharanunni Neelam Varma Reena Das |
| Publication date | August 27, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |